SCHEMBL9904902

SCHEMBL9904902

Cc1nc(=O)c(Cc2cncnc2)c[nH]1

nearest known ligand 0.43

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PLA2G7 Q13093 15/20 0.43
ADORA2A P29274 2/20 0.34
ADORA1 P30542 2/20 0.34
PNP P00491 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9103190 0.80 PLA2G7 (0.43) PLA2G7ADORA2AADORA1
SCHEMBL9904824 0.70 PLA2G7 (0.39) PLA2G7
SCHEMBL28095903 0.69 PLA2G7 (0.47) PLA2G7
SCHEMBL4415229 0.68 PLA2G7 (0.43) PLA2G7PNP
SCHEMBL17226664 0.66 PLA2G7 (0.34) PLA2G7
SCHEMBL8404454 0.64
SCHEMBL28096269 0.64 PLA2G7 (0.45) PLA2G7
SCHEMBL9106022 0.64 PLA2G7 (0.67) PLA2G7
SCHEMBL27756202 0.62 HTT (0.49) PLA2G7
SCHEMBL28096268 0.62 PLA2G7 (0.38) PLA2G7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2649053-A1 PYRIMIDINONE COMPOUNDS FOR USE IN THE TREATMENT OF DISEASES OR CONDITIONS MEDIATED BY LP - PLA2 Glaxo Group Limited (GB) 2013-10-16 EP disclosed
WO-2012076435-A1 PYRIMIDINONE COMPOUNDS FOR USE IN THE TREATMENT OF DISEASES OR CONDITIONS MEDIATED BY LP - PLA2 GLAXO GROUP LIMITED (GB) 2012-06-14 WO disclosed